arrow
K

Kit C. B. Roes

Medicines Evaluation Board
H指数:35
被引数:4,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop

优化患者登记系统以支持监管决策制定——来自HMA/EMA多利益相关方研讨会的关键经验

2025-06-020
OAAI
SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology

SIMPATHIC: 通过利用临床和分子病理学的相似性来加速罕见疾病的药物再利用

2025-03-010
PRE
Ethnic differences in efficacy of drug treatment in patients with an acute manic episode: an individual patient data meta-analysis of randomized placebo-controlled trials

急性躁狂发作患者中药物治疗的种族差异:一项基于随机安慰剂对照试验的个体患者数据meta分析

2025-02-230
OAAI
Clinical Evidence 2030

临床证据2030

2025-02-140
OAAI
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
2024-01-044
OAAI
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
2023-08-2768
OA
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4
2022-12-0913
OAAI